neither the vaccine nor the disease is comparable between the trial subjects, and no surrogate models exist to investigate biological activity of these products. As such, standard potency assays ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

This important study explores the conserved role of IgM in both systemic and mucosal antiviral immunity in teleosts, challenging established views on the differential roles of IgT and IgM. The ...

† From the US Bureau of Labor Statistics for wages of a medical assistant [11]. ‡ From the 2009 Red Book™ [12]. § Average price – IMS MIDAS – Price differential is individually ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...